Skip to content

Self-guided digital support reduced reported ADHD symptoms alongside usual care

Adults assigned to attexis plus routine treatment reported fewer ADHD symptoms than those receiving routine treatment alone, with benefits described as persisting at follow-up.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Adding attexis to usual treatment reduced self-reported ADHD symptom severity compared with usual treatment alone. The abstract also reports improvements in daily functioning and other psychological outcomes, with effects maintained at follow-up. This supports an added benefit in the studied setting, while leaving questions about longer-term effects and which parts of the program account for improvement.

Keep in mind

This abstract-based summary cannot assess adherence or missing data, which are not described. The primary outcome was self-reported, and the comparator did not include a matched digital program.

THE NUMBERS, WITH CONTEXT

What researchers found

-5.0 points

Baseline-adjusted mean difference in ADHD symptom severity

Adult ADHD Self-Report Scale total score at 3 months: attexis plus usual treatment versus usual treatment alone; p < .001.

Psychol Med, 2026 · Original source ↓

Symptoms and daily life

The main result concerns a symptom questionnaire, while secondary measures covered functional impairment, mood, self-esteem and quality of life. The abstract reports improvements across these measures but does not provide their individual effect sizes.

An addition to care

The program was tested as an addition to existing care. The trial therefore addresses its contribution alongside routine treatment; it does not establish how the program would perform as a replacement for that care. No program-related adverse events were reported.

CHECK THE ORIGINAL

The original publication

Effectiveness of attexis, a digital intervention based on cognitive behavioral therapy for adults with ADHD: a randomized controlled trial.

D'Amelio R, Betz LT, Jow SM et al.
Psychol Med · 2026

PubMed ID
41810578
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.